Actualités Neurobiological Technologies (MM) - NTII | Actions NASDAQ | ADVFN

Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.

S'inscrire

Accueil
Investir
Actions
Etats-Unis
NASDAQ
Neurobiological Technologies (MM) (NTII)
Neurobiological Technologies (MM) (NTII) Actualités

Neurobiological Technologies (MM) (NTII)

0,13

0,00

(0,00%)

Fermé 21 Janvier 10:00PM

Retardé de 15 minutes

0,00

0,00

(0,00%)

Après les heures de négociation: -

Retardé de 15 minutes

Outils de qualité professionnelle, pour des investisseurs individuels.

- Current report filing (8-K)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or...

-National Securities Exchange Report the Removal from listing and reg. of matured,redeemed or retired securities (25)

OMB Number: 3235-0080 Expires: January 31, 2012 Estimated average burden hours per response. . . . . . . 1.00 ...

- Current report filing (8-K)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13...

Neurobiological Technologies Announces Extraordinary Dividend of $0.18 per Share

Company also Announces Timing and Plans to Voluntarily Delist from the Nasdaq Capital Market and Initiate Dissolution Process EMERYVILLE, Calif...

- Quarterly Report (10-Q)

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark...

- Statement of Changes in Beneficial Ownership (4)

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...

- Statement of Changes in Beneficial Ownership (4)

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...

- Statement of Changes in Beneficial Ownership (4)

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...

- Statement of Changes in Beneficial Ownership (4)

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...

- Statement of Changes in Beneficial Ownership (4)

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...

- Statement of Changes in Beneficial Ownership (4)

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...

- Current report filing (8-K)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or...

Neurobiological Technologies Announces Stockholder Approval of Plan of Liquidation and Dissolution

Board of Directors Declares Extraordinary Dividend of $0.75 per share EMERYVILLE, Calif., Oct. 28 /PRNewswire-FirstCall/ -- Neurobiological...

- Statement of Changes in Beneficial Ownership (4)

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...

- Initial Statement of Beneficial Ownership (3)

FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL...

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Neurobiological

Delayed Upgrade Clock

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales